Results 251 to 260 of about 343,938 (360)

Increased Plasma Immunoreactive 6-Keto-Prostaglandin F1α Levels in Newborns with Idiopathic Respiratory Distress Syndrome [PDF]

, 1982
Pekka Kääpä, Maila Koivisto, Lasse Viinikka, Olavi Ylikorkala   +3 more
openalex   +1 more source

Guideline for the diagnosis, treatment, and prevention of respiratory syncytial virus infection in children in China

Pediatric Investigation, EarlyView.
ABSTRACT Respiratory syncytial virus (RSV) is one of the most common respiratory pathogens in children under 5 years of age worldwide and it seriously threatens children's health. In recent years, great progress has been made in the field of RSV‐related diseases.
Committee of Pediatrics, China Medical Education Association, Subspecialty Group of Respiratory Diseases, Society of Pediatrics, Chinese Medical Association, Pediatric Respiratory Work Committee, Society of Pulmonologists, Chinese Medical Doctor Association, Committee of Pediatrics, Chinese Research Hospital Association, Pediatric Professional Committee of China Non‐public Medical Institution Association, Professional Committee of Children's Health and Pharmaceutical Research, China Association of Traditional Chinese Medicine, Children's Safe Medication Branch of China Medical News and Information Association, Pediatric Expert Committee of China Primary Health Care Foundation, Global Pediatric Respiratory Alliance, Beijing Hairun Charity Foundation   +16 more
wiley   +1 more source

Prenatal Thyroid Function Abnormalities in Infants with Idiopathic Respiratory Distress Syndrome [PDF]

, 1984
Val Abbassi, James M. Adams, Daniel Duvall, Elizabeth Phillips   +3 more
openalex   +1 more source

Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract The use and misuse of opioids has surged in the past decade, with nearly half of the users being female. Although opioid use is lower among pregnant women, trends mirror the general population. While pediatric exposures largely occur through prescriptions.
Aditi Shendre, Xiaofu Liu, ChienWei Chiang, Andrew Goodwin, Samuel‐Richard Oteng, Jiezel A. F. Deypalubos, Shijun Zhang, Lei Wang, Jianing Liu, Mohammad Yaseen Abbasi, Blessed Winston Aruldhas, Syed Saoud Zaidi, Lindsey Marie Kirkpatrick, Lais Da Silva, Brian R. Overholser, Aislinn M. O’Kane, Prince J. Kannankeril, Stephen W. Patrick, Andrew D. Wiese, Sara K. Quinney, Lang Li   +20 more
wiley   +1 more source

Nomogram risk prediction model for acute respiratory distress syndrome following acute kidney injury. [PDF]

Front Med (Lausanne)
Lin H, Ren Y, Cui J, Guo J, Wang M, Wang L, Su X, Qiao X.   +7 more
europepmc   +1 more source

1295 EFFECTIVENESS OF VITAMIN E (E) ADMINISTRATION DURING RESPIRATORY DISTRESS SYNDROME (RDS) IN PREVENTING RETROLENTAL FIBROPLASIA (RLF) [PDF]

, 1981
Richard A. Ehrenkranz, James E. Puklin, Joseph B. Warshaw   +2 more
openalex   +1 more source

Value of serum NT proBNP, HMGB1, and SIRT1 in the diagnosis and prognosis of neonatal respiratory distress syndrome. [PDF]

Pak J Med Sci
Yang Q, Zhu H.
europepmc   +1 more source

Respiratory distress syndrome

, 2022
openaire   +1 more source

Disease–Drug–Drug Interaction of Imatinib in COVID‐19 ARDS: A Pooled Population Pharmacokinetic Analysis

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 583-595, March 2025.
ABSTRACT Prior pharmacokinetic (PK) analysis revealed that increased alpha‐1‐acid glycoprotein (AAG) levels are associated with decreased imatinib unbound fraction in coronavirus disease 2019 (COVID‐19) patients. This study aimed to investigate the PK of total and unbound concentrations of imatinib and the metabolite N‐desmethyl imatinib in ...
Medhat M. Said, Job R. Schippers, Leila Atmowihardjo, Yingxue Li, Mick S. van der Plas, Harm J. Bogaard, Lieuwe D. J. Bos, Ron A. A. Mathôt, Jurjan Aman, Eleonora L. Swart, Imke H. Bartelink   +10 more
wiley   +1 more source

Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies. [PDF]

Signal Transduct Target Ther
Ma W, Tang S, Yao P, Zhou T, Niu Q, Liu P, Tang S, Chen Y, Gan L, Cao Y.   +9 more
europepmc   +1 more source